Pages that link to "Q44851452"

The following pages link to A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. (Q44851452):

Displaying 17 items.

• cAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension (Q28822014) (← links)
• Autoantibodies and cardiovascular dysfunction: cause or consequence? (Q34473885) (← links)
• β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways (Q34541400) (← links)
• Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload (Q35023544) (← links)
• Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass. (Q36971570) (← links)
• Autoantibodies and cardiac arrhythmias (Q37374540) (← links)
• The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease (Q37824303) (← links)
• The Diagnostic and Clinical Significance of Anti-Muscarinic Receptor Autoantibodies (Q37826112) (← links)
• The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease (Q37826114) (← links)
• Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function (Q37973384) (← links)
• β1 -adrenergic receptor autoantibodies from heart failure patients enhanced TNF-α secretion in RAW264.7 macrophages in a largely PKA-dependent fashion (Q39342487) (← links)
• Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy (Q43626109) (← links)
• Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients (Q50544791) (← links)
• Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors (Q51125254) (← links)
• Autoantibody against β-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4 T cells by up-regulating AMPK-mediated fatty acid oxidation (Q61795841) (← links)
• Diagnostic and prognostic value of autoantibodies against β1-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study (Q89495747) (← links)
• Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome (Q90641212) (← links)